Literature DB >> 35194735

The Protective Effect of miR-27-3p on Ischemia-Reperfusion-Induced Myocardial Injury Depends on HIF-1α and Galectin-3.

Ziguang Song1, Xiao Zhong1, Zhongping Ning2, Xiang Song3.   

Abstract

Cardiac ischemia-reperfusion injury usually results in acute myocardial infarction (AMI). MiRNAs have been identified as key regulators of AMI. This study was carried out to investigate the effect of miR-27-3p on cardiomyocyte injury in AMI. CCK-8 and flow cytometry assays were used to evaluate cell viability and apoptosis. The expression levels of miR-27-3p, galectin-3, and hypoxia-inducible factor-1α were measured by qRT-PCR. The relationship among miR-27-3p, galectin-3, and HIF-1α was assessed by bioinformatics analysis and luciferase assay. The effects of miR-27-3p and/or galectin-3 and HIF-1α on the inhibition of cell viability and apoptosis induced by H/R were explored. The expression levels of apoptosis-related proteins were determined by Western blot analysis. The expression levels of miR-27-3p were reduced in both ischemia-reperfusion myocardium and HL-1 cells during hypoxia. Overexpression of miR-27-3p reduced I/R-induced myocardial injury, and HIF-1α can reduce this effect. H/R reduced the expression levels of miR-27-3p in HL-1 cardiomyocytes, and HIF1-α reduced this effect, indicating that HIF1-α could regulate the expression of miR-27-3p, and galectin-3 was a target of miR-27-3p. Finally, overexpression of galectin-3 reduced the protective effect of miR-27-3p on cardiomyocyte injury. The expression levels of HIF1-α were increased, and miR-27-3p was downregulated after AMI. HIF-1α promoted myocardial protection by upregulating miR-27-3p, and downregulation of miR-27-3p promoted myocardium cell injury by targeting galectin-3.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Acute myocardial infarction; Apoptosis; Galectin-3; HIF-1α; miR-27-3p

Year:  2022        PMID: 35194735     DOI: 10.1007/s12265-021-10203-y

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  22 in total

Review 1.  Galectin-3: is this member of a large family of multifunctional lectins (already) a therapeutic target?

Authors:  Antonio Romero; Hans-Joachim Gabius
Journal:  Expert Opin Ther Targets       Date:  2019-10-22       Impact factor: 6.902

Review 2.  The Role of Non-coding RNAs in Ischemic Myocardial Reperfusion Injury.

Authors:  Vince Siebert; Joseph Allencherril; Yumei Ye; Xander H T Wehrens; Yochai Birnbaum
Journal:  Cardiovasc Drugs Ther       Date:  2019-08       Impact factor: 3.727

3.  Bishonokiol A inhibits breast cancer cell invasion and migration by suppressing hypoxia inducible factor-1α.

Authors:  Hong-Mei Li; Jian Miao; Meilin Zhu; Meijia Gao; Yiqun Dai; Qiang Huo; Tao Ma; Cheng-Zhu Wu
Journal:  J Bioenerg Biomembr       Date:  2019-05-06       Impact factor: 2.945

Review 4.  MicroRNAs in the atherosclerotic plaque.

Authors:  Emma Raitoharju; Niku Oksala; Terho Lehtimäki
Journal:  Clin Chem       Date:  2013-05-31       Impact factor: 8.327

5.  miR-124-5p/NOX2 Axis Modulates the ROS Production and the Inflammatory Microenvironment to Protect Against the Cerebral I/R Injury.

Authors:  Yakun Wu; Jia Yao; Kai Feng
Journal:  Neurochem Res       Date:  2020-01-16       Impact factor: 3.996

6.  Iron overload as a risk factor for hepatic ischemia-reperfusion injury in liver transplantation: Potential role of ferroptosis.

Authors:  Naoya Yamada; Tadayoshi Karasawa; Taiichi Wakiya; Ai Sadatomo; Homare Ito; Ryo Kamata; Sachiko Watanabe; Takanori Komada; Hiroaki Kimura; Yukihiro Sanada; Yasunaru Sakuma; Koichi Mizuta; Nobuhiko Ohno; Naohiro Sata; Masafumi Takahashi
Journal:  Am J Transplant       Date:  2020-02-03       Impact factor: 8.086

7.  An in Vivo miRNA Delivery System for Restoring Infarcted Myocardium.

Authors:  Huaxiao Yang; Xulei Qin; Huiyuan Wang; Xin Zhao; Yonggang Liu; Hung-Ta Wo; Chun Liu; Masataka Nishiga; Haodong Chen; Jing Ge; Nazish Sayed; Oscar J Abilez; Dan Ding; Sarah C Heilshorn; Kai Li
Journal:  ACS Nano       Date:  2019-06-07       Impact factor: 15.881

8.  MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2.

Authors:  Lin Zhou; Xin Liang; Lingling Zhang; Liyan Yang; Norio Nagao; Hongkun Wu; Chang Liu; Shengchao Lin; Guoxiang Cai; Jianwen Liu
Journal:  Oncotarget       Date:  2016-08-09

9.  XingNaoJing injection ameliorates cerebral ischaemia/reperfusion injury via SIRT1-mediated inflammatory response inhibition.

Authors:  Yue-Ming Zhang; Xiao-Yu Qu; Li-Na Tao; Jing-Hui Zhai; Huan Gao; Yan-Qing Song; Si-Xi Zhang
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

10.  Pancreatic secretory trypsin inhibitor reduces multi-organ injury caused by gut ischemia/reperfusion in mice.

Authors:  Raymond J Playford; Tania Marchbank
Journal:  PLoS One       Date:  2020-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.